Cargando…
CD4/CD8 ratio is not predictive of multi-morbidity prevalence in HIV-infected patients but identify patients with higher CVD risk
BACKGROUND: CD4/CD8<0.8 is a surrogate marker of immune-activation/immunosenescence and independently predicts mortality in the HIV-infected patients due to non-AIDS related events. Most studies showed that patients on antiretroviral therapy (ART) often fail to normalize the CD4/CD8 ratio despite...
Autores principales: | Menozzi, Marianna, Zona, Stefano, Santoro, Antonella, Carli, Federica, Stentarelli, Chiara, Mussini, Cristina, Guaraldi, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International AIDS Society
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225275/ https://www.ncbi.nlm.nih.gov/pubmed/25397456 http://dx.doi.org/10.7448/IAS.17.4.19709 |
Ejemplares similares
-
Lésions acrales chroniques (« orteils COVID ») : un syndrome post-COVID long ?
por: André, Raphaël, et al.
Publicado: (2021) -
The dynamic association between Frailty, CD4 and CD4/CD8 ratio in people aging with HIV
por: Guaraldi, Giovanni, et al.
Publicado: (2019) -
Efficacy Of Bedside Cannulation For Percutaneous Ventricular Assist Devices
por: Patel, Nishi H., et al.
Publicado: (2022) -
Impact de la pandémie COVID-19 sur la prise en charge des néoplasies bronchopulmonaires
por: Belaid, Z., et al.
Publicado: (2023) -
Relationship Between Covid-19 And Donor Specific Antibodies In Orthotopic Heart Transplant Recipients
por: Yang, Bin Q, et al.
Publicado: (2023)